Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Togashi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|April 24, 2002
[Genetically engineered mice and its application to bioindustry]Toshiaki Koda, Yuji Togashi, Takashi Nishimura
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 3, 2005
[Development of DNA array filter useful for the analysis of Th1/Th2 balance]Aki Yamaguchi, Yuji Togashi, Toshiaki Koda, et al.
Immunology Letters|May 6, 2014
Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccineJunya Ohtake, Takayuki Ohkuri, Yuji Togashi, et al.
Immunology Letters|December 6, 2014
Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacyKazutaka Masuko, Daiko Wakita, Yuji Togashi, et al.
Immunology Letters|January 21, 2014
Identification of a meiosis-specific protein, MEIOB, as a novel cancer/testis antigen and its augmented expression in demethylated cancer cellsYasuo Shiohama, Junya Ohtake, Takayuki Ohkuri, et al.
International Immunology|January 19, 2007
AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunityAkemi Kosaka, Daiko Wakita, Naoki Matsubara, et al.
Cancer Science|March 16, 2007
Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramideYuji Togashi, Kenji Chamoto, Daiko Wakita, et al.
Cancer Research|March 11, 2010
Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapyTsuguhide Takeshima, Kenji Chamoto, Daiko Wakita, et al.
Immunology Letters|August 25, 2004
NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivoKenji Chamoto, Tsuguhide Takeshima, Akemi Kosaka, et al.
Cancer Science|September 6, 2006
Interleukin-12-responding asialoGM1+CD8+ central memory-type T cells as precursor cells for interferon-gamma-producing killer T cellsAkemi Kosaka, Ushaku Lee, Daiko Wakita, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|April 24, 2002
[Genetically engineered mice and its application to bioindustry]Toshiaki Koda, Yuji Togashi, Takashi Nishimura
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 3, 2005
[Development of DNA array filter useful for the analysis of Th1/Th2 balance]Aki Yamaguchi, Yuji Togashi, Toshiaki Koda, et al.
Immunology Letters|May 6, 2014
Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccineJunya Ohtake, Takayuki Ohkuri, Yuji Togashi, et al.
Immunology Letters|December 6, 2014
Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacyKazutaka Masuko, Daiko Wakita, Yuji Togashi, et al.
Immunology Letters|January 21, 2014
Identification of a meiosis-specific protein, MEIOB, as a novel cancer/testis antigen and its augmented expression in demethylated cancer cellsYasuo Shiohama, Junya Ohtake, Takayuki Ohkuri, et al.
International Immunology|January 19, 2007
AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunityAkemi Kosaka, Daiko Wakita, Naoki Matsubara, et al.
Cancer Science|March 16, 2007
Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramideYuji Togashi, Kenji Chamoto, Daiko Wakita, et al.
Cancer Research|March 11, 2010
Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapyTsuguhide Takeshima, Kenji Chamoto, Daiko Wakita, et al.
Immunology Letters|August 25, 2004
NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivoKenji Chamoto, Tsuguhide Takeshima, Akemi Kosaka, et al.
Cancer Science|September 6, 2006
Interleukin-12-responding asialoGM1+CD8+ central memory-type T cells as precursor cells for interferon-gamma-producing killer T cellsAkemi Kosaka, Ushaku Lee, Daiko Wakita, et al.
Pageof 3